Anthrax in England and Wales 1963-1972.

The Veterinary Record
M E Hugh-Jones, S N Hussaini

Abstract

The records of confirmed anthrax diagnoses held by the bacteriology department of the Central Veterinary Laboratory, Weybridge, for the years 1963 to 1972 inclusive, were analysed. During this decade, 86 per cent of the 2944 deaths recorded were in cattle and 11 per cent in pigs, correlating significantly with the cattle and pig populations in England and Wales during this period. Also, the country could be separated into high and low prevalence counties for cattle anthrax. Norfolk and Somerset had higher than usual cattle deaths per farm ratios and the reasons for this are explored.

Citations

Sep 15, 2001·Journal of Applied Microbiology·D C DragonB T Elkin
Nov 27, 2015·Zoonoses and Public Health·S Babo MartinsK D C Stärk
Sep 25, 2012·Journal of Veterinary Science·Hetron Mweemba Munang'anduByman Hamududu
Jun 28, 2016·Journal of Applied Microbiology·A M BennettS R Parks
Oct 27, 2018·Transboundary and Emerging Diseases·Jiang-Yong ZengMieghan Bruce
Mar 29, 2019·Veterinary Medicine and Science·Harvey K KamboyiMusso Munyeme
Sep 11, 2018·The Onderstepoort Journal of Veterinary Research·Doreen C SitaliMusso Munyeme

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.